Published on

CDSCO Manufacturing License for Analgesic PENS system

Authors
  • avatar
    Name
    CDSCO Licenses Blog
    Twitter

Introduction

The Central Drugs Standard Control Organization (CDSCO) is a crucial authority in the Indian healthcare sector. It plays an instrumental role in approving drugs, conducting clinical trials, laying down the standards, and controlling the quality of drugs imported into and exported from the country. In addition to drugs, the CDSCO also regulates the manufacture and distribution of medical devices in India.

The medical device industry is highly significant as it continually evolves and brings forth advanced equipment and technology that aid in diagnosis, prevention, and treatment of various health conditions. One such medical device is the Analgesic PENS (Percutaneous Electrical Nerve Stimulation) system. This device is primarily used for delivering controlled electrical impulses directly to the subcutaneous tissue. It serves as a substantial relief for chronic neuropathic pain.

A manufacturing license issued by the CDSCO is required to manufacture any medical device in India, including the Analgesic PENS system. This license proves the efficiency, quality, and safety of any medical device. The CDSCO's portal [https://cdscomdonline.gov.in/NewMedDev/Homepage] offers further details.

What is Analgesic PENS system?

The Analgesic PENS system is a medical device used for pain management. Controlled electrical impulses are delivered directly to the patient’s subcutaneous tissue, typically in the vicinity of a peripheral nerve, for relief from chronic neuropathic pain. This non-invasive treatment plan aids those suffering from long-term nerve pain, making their condition more manageable.

The device plays a significant role in pain management treatment procedures, particularly for those patients for whom conventional pain relief methods have proved ineffective. By directly stimulating the nerves, it seeks to relieve pain in an innovative and non-invasive way.

The Role of CDSCO in Medical Device Regulation

The Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health & Family Welfare, Government of India plays a key role in the regulation of medical devices. It is its responsibility to ensure that every medical device manufactured and distributed in India adheres to the set standards of quality and safety.

The organization introduced the Medical Devices Rules in 2017, further clarifying and effectively managing the regulatory framework for medical devices in India. Including medical devices in the ambit of the Drugs and Cosmetics Act has increased regulatory scrutiny ensuring superior quality and effectiveness.

How to manufacture Analgesic PENS system

Administering the production of medical devices like the Analgesic PENS system requires compliance with several regulations and guidelines. Rigorous testing, quality control checks and validation studies are necessary to ensure the effectiveness and safety of the device.

Fees for manufacturing license for Analgesic PENS system

As the Analgesic PENS system falls under Risk Class B, the manufacturing license required would be MD5. The fees for obtaining the MD5 license amount to Rs. 5,000 for the license and an additional Rs. 500 per product.

Why is a Manufacturing License Necessary for Analgesic PENS system?

A manufacturing license is obligatory for creating a medical device like the Analgesic PENS system. This license ensures that the device is safe and of high quality. Regulatory compliance is extremely significant in the healthcare sector as it safeguards patients from substandard products by enforcing stringent manufacturing standards.

Steps to Obtain a CDSCO Manufacturing License for Analgesic PENS system

Obtaining a CDSCO manufacturing license involves a series of steps including the preparation of necessary documents, device master file, quality management certificate, device details, and site details among others. The application is then to be duly submitted for approval. The process may present certain hurdles but with the right guidance and persistence, these can be seamlessly overcome.

Frequently Asked Questions (FAQs)

Q1: What is risk class of Analgesic PENS system as per Medical Device Rules, 2017?

Risk Class for Analgesic PENS system is B.

Q2: What license in needed to manufacture Analgesic PENS system?

MD5 license is required to manufacture Analgesic PENS system.

Q3: What is fees for MD5 license for Analgesic PENS system?

The fees for the MD5 license amount to Rs. 5,000 for the license and Rs. 500 per product.

Q4: Who will issue manufacturing license for Analgesic PENS system?

State FDA will issue the MD5 license for Class B devices like Analgesic PENS system.

Q5: Is repackaging of Analgesic PENS system considered manufacturing?

Yes, as per Drugs and Cosmetics Act's definition of manufacturing, repackaging of drugs is considered manufacturing, and medical devices come under this definition. Therefore, repackaging of Analgesic PENS system also requires a license - MD5 in this case.

Conclusion

Obtaining a CDSCO manufacturing license is an essential step for every manufacturer in the Indian healthcare industry. To assist with any queries or ambiguities regarding the licensing process, you can reach out to Pharmadocx Consultants at "+91-7404557227" or email "[email protected]". You can also visit https://www.pharmadocx.com for more information.

Should you be interested in an MD5 license for manufacturing medical devices in India, this article will provide you with detailed information: https://pharmadocx.com/md-5-licesne-class-a-b-medical-devices/.

cdsco import license in india banner
cdsco manufacturing license in india banner